Analyzing microarray datasets, no difference in the IDH1 or H3F3a mutational status was found between the two GBM subgroups, but the value of this analysis is limited by the low number of samples used for IDH1 and H3F3a analysis. The gene discussed is IDH1; the disease is glioblastoma.